Arcadia Biosciences, Inc.
New Form D on file · 2026-06-26 · the record
Arcadia Biosciences, Inc. filed a Form D with the Securities and Exchange Commission on 2026-06-26.
Arcadia Biosciences, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 26, 2026. The filing reports $4M sold. Its industry group is Other Technology. It names Thomas Schaefer (Executive Officer, Director), Kevin Comcowich (Director), Amy Yoder (Director) (SEC Form D, June 26, 2026).
Who owns Arcadia Biosciences, Inc.?
Sell to companies like Arcadia Biosciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
88 companies raised this week, 1 had other signals.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| fal - Features & Labels, Inc. | $1B | AI and software |
| fal - Features & Labels, Inc. | $350M | AI and software |
| SIERRA INTERNATIONAL NETWORK INC | $300M | AI and software |
| Zai Lab Ltd | $250M | Biotech |
| Databento Inc. | $100M | AI and software |
Is this your company?
New Form D on file · 2026-06-26 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Arcadia Biosciences, Inc.
Free to see. No signup.
More on the people and the money behind Arcadia Biosciences, Inc., from the filings we hold.
H.C. Wainwright & Co, LLC received sales compensation on this raise and on 29 other raises we hold, nearest in date first:
Other Technology raises by companies based in Texas, filed in June 2026, largest first.
Get an email when Arcadia Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Arcadia Biosciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Arcadia Biosciences, Inc. →Get the full cited report on Arcadia Biosciences, Inc.
What the filing shows about Arcadia Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Arcadia Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look Arcadia Biosciences, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Arcadia Biosciences, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives Arcadia Biosciences, Inc.'s address as 5956 Sherry Lane, Suite 2000, Dallas, TX 75225.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Arcadia Biosciences, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Arcadia Biosciences, Inc. See pricing
Arcadia Biosciences, Inc. is a registered filer with the SEC (CIK 1469443) and has filed since 2026-01-27. 2 filings are on record, the latest on 2026-06-26.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Arcadia Biosciences, Inc.'s Form D of 2026-06-26 names Thomas Schaefer, Kevin Comcowich, Amy Yoder and 2 more as its officers, directors or promoters.
Its new offerings report $6.08M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3831 filings in Other Technology, totalled by week. The dot is this raise, $4M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Thomas Schaefer is named as Executive Officer and Director on the Form D that Arcadia Biosciences, Inc. filed with the SEC on 26 June 2026, one of 5 people that filing names.
Kevin Comcowich is named as Director on the Form D that Arcadia Biosciences, Inc. filed with the SEC on 26 June 2026, one of 5 people that filing names.
Amy Yoder is named as Director on the Form D that Arcadia Biosciences, Inc. filed with the SEC on 26 June 2026, one of 5 people that filing names.
Lilian Murray is named as Director on the Form D that Arcadia Biosciences, Inc. filed with the SEC on 26 June 2026, one of 5 people that filing names.
Gregory Waller is named as Director on the Form D that Arcadia Biosciences, Inc. filed with the SEC on 26 June 2026, one of 5 people that filing names.
5 people named on the filing — 1 holding an executive role and 4 as directors only.
Named as of the 2026-06-26 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Arcadia Biosciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Arcadia Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Arcadia Biosciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Arcadia Biosciences, Inc.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (arcadiabio.com).
Each opens in a new tab, filled in for Arcadia Biosciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Dallas-Fort Worth
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/arcadia-biosciences-inc-form-d-26000001